"ViCToRy: Vorasidenib in Combination with Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas

Clinical Trial Grant

Duke Scholars

Principal Investigator Katherine Barnett Peters Neurosurgery, Neuro-Oncology

Awarded By

Servier Pharmaceuticals

Start Date

September 30, 2024

End Date

August 31, 2028

Awarded By

Servier Pharmaceuticals

Start Date

September 30, 2024

End Date

August 31, 2028